Kanzhun Ltd: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Apr 29, 2024 and accepted by EDGAR at Apr 29, 2024, 06:48 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $838.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $149.3m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $217.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | $81.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $17.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | $154.8m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $0.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $0.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 902,735,995 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $429.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $134.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $79.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $10.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $348.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $1.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $2.53bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $613.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $635.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-12-31 | $1.89bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-24-053379. Last ingested by Listed: Nov 5, 2026, 16:23 ET. Listed shows no prices and gives no investment advice.